Compounds > 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium
Page last updated: 2024-09-05

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and 1-methyl-4-phenylpyridinium

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Compound Research Comparison

Studies
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)		Trials
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)		Recent Studies (post-2010)
(1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium)		Studies
(1-methyl-4-phenylpyridinium)		Trials
(1-methyl-4-phenylpyridinium)		Recent Studies (post-2010) (1-methyl-4-phenylpyridinium)
5011,8541593

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, KE; Billett, EE; De Girolamo, LA; Griffin, M1

Other Studies

1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and 1-methyl-4-phenylpyridinium

ArticleYear
The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.
    Neuroscience letters, 2006, Sep-11, Volume: 405, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; Cell Differentiation; Cell Line, Tumor; Cell Survival; GTP-Binding Proteins; Humans; Imidazoles; Neuroblastoma; Parkinson Disease; Polyamines; Protein Glutamine gamma Glutamyltransferase 2; Putrescine; Transglutaminases

2006